Page last updated: 2024-10-29

isocarboxazid and Metabolism, Inborn Errors

isocarboxazid has been researched along with Metabolism, Inborn Errors in 2 studies

Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

Metabolism, Inborn Errors: Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Watts, RW1
Chalmers, RA1
Gibbs, DA1
Lawson, AM1
Purkiss, P1
Spellacy, E1
Bourke, E1
Frindt, G1
Flynn, P1
Schreiner, GE1

Other Studies

2 other studies available for isocarboxazid and Metabolism, Inborn Errors

ArticleYear
Studies on some possible biochemical treatments of primary hyperoxaluria.
    The Quarterly journal of medicine, 1979, Volume: 48, Issue:190

    Topics: Adolescent; Adult; Animals; Child; Cholestyramine Resin; Female; Haplorhini; Humans; Isocarboxazid;

1979
Primary hyperoxaluria with normal alpha-ketoglutarate: glyoxylate carboligase activity. Treatment with isocarboxazid.
    Annals of internal medicine, 1972, Volume: 76, Issue:2

    Topics: Allopurinol; Child; Female; Glycolates; Glyoxylates; Humans; Isocarboxazid; Ketoglutaric Acids; Kidn

1972